Sodium Hydrosulfide Attenuates Beta-Amyloid-Induced Cognitive Deficits And Neuroinflammation Via Modulation Of Mapk/Nf-Kappa B Pathway In Rats

Huiyu Liu,Yuanyuan Deng,Jianmei Gao,Yuangui Liu,Wenxian Li,Jingshan Shi,Qihai Gong
DOI: https://doi.org/10.2174/1567205012666150713102326
2015-01-01
Current Alzheimer Research
Abstract:Beta-amyloid (A beta), a neurotoxic peptide, accumulates in the brain of Alzheimer's disease (AD) subjects to initiate neuroinflammation eventually leading to memory impairment. Here, we demonstrated that A beta-injected rats exhibited cognitive impairment and neuroinflammation with a remarkable reduction of hydrogen sulfide (H2S) levels in the hippocampus compared with that in sham-operated rats. Interestingly, the expression of cystathionine-beta-synthase (CBS) and 3-mercaptopyruvate-sulfurtransferase (3MST), the major enzymes responsible for endogenous H2S generation, were also significantly decreased. However, intraperitoneal (i.p.) injection of sodium hydrosulfide (NaHS, a H2S donor) dramatically attenuated cognitive impairment and neuroinflammation induced by hippocampal injection of 10 mu g of A beta(1-42) in rats. Subsequently, NaHS significantly suppressed the expression of tumor necrosis factor (TNF)-alpha, interleukin-1 beta (IL-1 beta) and cyclooxygenase-2 (COX-2) in rat hippocampus following A beta administration. Furthermore, NaHS exerted a beneficial effect on inhibition of I kappa B-alpha degradation and subsequent activation of transcription factor nuclear factor kappa B (NF-kappa B), as well as inhibition of extracellular signal-regulated kinase (ERK1/2) activity and p38 MAPK activity but not c-Jun N-terminal kinase (JNK) activity induced by A beta. These results demonstrate that NaHS might be a potential agent for treatment of neuroinflammation-related AD.
What problem does this paper attempt to address?